TAVI using the Trilogy valve is feasible and offers advantages over other commercial platforms for treating degenerated Freestyle grafts with flail left coronary cusps.
Is TAVI using the Trilogy valve feasible for patients with degenerated Freestyle graft with flail left coronary cusp?
TAVI using the Trilogy valve is a feasible option for treating degenerated Freestyle grafts with a flail left coronary cusp.
Absolute Event Rate: 0% vs 0%
TAVI using the Trilogy valve for degenerated Freestyle graft with flail left coronary cusp is feasible, with several advantages over commercially available TAVI platforms. However, additional cases are required to demonstrate its safety and reproducibility.
“Valve-in-valve TAVI for degenerated Freestyle valves is technically challenging because of the stentless frame with limited anchoring support and distortion of the aortic root anatomy, which can lead to a higher risk of complications using commercially available TAVI platforms, including valve malposition and coronary obstruction. Dedicated TAVI devices for aortic regurgitation, such as the Trilogy valve, provide active fixation by radial force generated by the nitinol frame, along with 3 locators positioned within each sinus to secure the native aortic valve leaflets between the locators and valve frame, thereby enhancing anchoring and stability in the absence of leaflet or annular calcium.”
Al-Shaibi et al. (Wed,) reported a other. TAVI using the Trilogy valve is feasible and offers advantages over other commercial platforms for treating degenerated Freestyle grafts with flail left coronary cusps.